Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.3.1. No changes to study details or other page content.SummaryDifference0.1%

- Check19 days agoChange DetectedPublications section updated: added notes that publications are provided voluntarily and auto-filled from PubMed, and the revision tag is now v3.3.1.SummaryDifference0.2%

- Check26 days agoChange DetectedThe funding-status notice regarding government operations has been removed from the page; core study details, eligibility criteria, and results information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedUpdated Study Record Dates and last update timestamp; core study content including condition, intervention, eligibility criteria, endpoints, and results remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedPage now displays a new version (v3.2.0) and includes a government-operating-status notice; the old version tag (v3.1.0) was removed.SummaryDifference1%

- Check76 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.